SCHEMBL6071832

SCHEMBL6071832

Cc1c(C#N)c(N)nc2cccc(-n3ccnn3)c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
HSD17B10 Q99714 5/20 0.35
HTT P42858 2/20 0.35
ADORA2A P29274 2/20 0.35
ADRA2A P08913 1/20 0.35
ALDH1A1 P00352 4/20 0.35
PIK3CD O00329 3/20 0.35
PIK3R1 P27986 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
KDM4E B2RXH2 4/20 0.34
MAPK1 P28482 2/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7842315 0.80 ALDH1A1 (0.43) CYP1A2HSD17B10HTTADORA2AALDH1A1
SCHEMBL20142746 0.71 NOTUM (0.41) CYP1A2CYP2C19KDM4EMAPTTSHR
SCHEMBL4561056 0.69 CYP19A1 (0.35) TSHRNOTUM
SCHEMBL6428993 0.69 NOTUM (0.44) CYP1A2CYP2C19CYP3A4GAACYP2C9
SCHEMBL4758723 0.68 HCRTR1 (0.36) ADORA2AKDM4E
SCHEMBL16681271 0.68 ALDH1A1 (0.47) CYP1A2CYP2C19CYP3A4GAACYP2D6
SCHEMBL18284703 0.68 NOTUM (0.38) CYP1A2CYP2C19CYP3A4GAACYP2D6
SCHEMBL6072086 0.67 IDO1 (0.43) HSD17B10HTTADORA2AADRA2AALDH1A1
SCHEMBL6253855 0.66 KDM4E (0.56) CYP1A2GAAHSD17B10HTTADORA2A
SCHEMBL30315435 0.66 KDM4E (0.56) CYP1A2GAAHSD17B10HTTADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same WYETH (US) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same TNNI3K, CSNK1A1L, CDKL1 CYP1A2 1959/4885CYP2C19 4143/4885CYP3A4 2706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.